FDA approves RSV vaccine for use in pregnant women to pass immunity to newborns

The Food and Drug Administration on Monday approved Pfizer’s vaccine against the RSV virus for use in pregnant women so they pass to their newborns immunity from the resulting respiratory disease.

Source: washingtontimes.com

Please follow and like us: